Reversal?Chart looks like the bottom is in and in the process of reversing...probably a multi year swing if this ends up cracking the last peak at $4.10
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.035 AUD
−42.72 M AUD
0.00 AUD
1.42 B
About IMMUTEP LIMITED
Sector
Industry
CEO
Marc Voigt
Website
Headquarters
Sydney
Founded
1987
ISIN
AU000000IMM6
FIGI
BBG000BLY887
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
IMMP - Swing IdeaAfter a reported 2M revenue compared to th3 145k expected, IMMP has been on a decent uptrend after finishing a double bottom.
If momentum continues, I can see a 3.09 IMMP easy
Blue box: Entry price
Red box: Stop loss
Green box: Take profit
immutep trendsKey trend lines on Immutep.
Immutep is close to breaking another key weekly trend line.
IMMUTEP Immutep hits a previous resistance and confirms it as a support,
we see oversold MACD and RSI which appear congruent with our idea of support.
IMMU can make its way to previous resistance now.
Trade Safe
Immutep ready for the next pushImmutep is nearly ready to push back up to previous highs or higher. wait for a cross above and fall back to confirm support on the ema on the daily. wait for macd crossover.
Sell at previous highs / resistances.
Taking This Chart out To Historic Levels With Pending CatalystIMMP has done great recovering from its last sell-off. But now it's back at a historic level of resistance that we clearly see on this chart right now. Upcoming potential catalyst this week will determine which direction it heads imo.
"Data from the TACTI-002 and INSIGHT-004 studies were publish
IMMP per request....I made another mess.Ok So I put lines everywhere from all over the place and in the confusion of it all some areas started to have some confluence.....everything kept pointing to $6.80. I appreciate the request to take a look at this.
by iCantw84it
05.27.2021
Please Like Subscribe if you would like to see more of th
Why $IMMP soared in December case studyFirst time an antigen presenting cell (APC) activator has shown an Overall Survival (OS) benefit in a randomised setting in metastatic breast cancer patients known to be insensitive to immune checkpoint inhibitor therapy
Promising and improving overall trend in OS in total population (based on appr
$IMMP: SmlCap play - Potential 20-80% upside from today's closesee boxes on chart for Entry, Exit and Stop loss zones. Never Chase.
Not for any recommendation, Just an Idea.
IMMP BullishThe MACD is curling up and it tested the .50 Fibonacci level. Also a few days ago it tested the 200 MA and bounced. This looks like a breakout over 1.82 with a first target of 2.12
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IMM is 0.335 AUD — it has decreased by −1.47% in the past 24 hours. Watch IMMUTEP LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange IMMUTEP LIMITED stocks are traded under the ticker IMM.
IMM stock has fallen by −2.90% compared to the previous week, the month change is a 15.52% rise, over the last year IMMUTEP LIMITED has showed a 0.95% increase.
We've gathered analysts' opinions on IMMUTEP LIMITED future price: according to them, IMM price has a max estimate of 2.00 AUD and a min estimate of 0.70 AUD. Watch IMM chart and read a more detailed IMMUTEP LIMITED stock forecast: see what analysts think of IMMUTEP LIMITED and suggest that you do with its stocks.
IMM stock is 3.03% volatile and has beta coefficient of 1.73. Track IMMUTEP LIMITED stock price on the chart and check out the list of the most volatile stocks — is IMMUTEP LIMITED there?
Yes, you can track IMMUTEP LIMITED financials in yearly and quarterly reports right on TradingView.
IMMUTEP LIMITED is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
IMM earnings for the last half-year are −0.02 AUD per share, whereas the estimation was −0.02 AUD, resulting in a 4.88% surprise. The estimated earnings for the next half-year are −0.02 AUD per share. See more details about IMMUTEP LIMITED earnings.
IMMUTEP LIMITED revenue for the last half-year amounts to 1.77 M AUD, despite the estimated figure of 2.69 M AUD. In the next half-year revenue is expected to reach 1.42 M AUD.
IMM net income for the last half-year is −21.49 M AUD, while the previous report showed −21.23 M AUD of net income which accounts for −1.23% change. Track more IMMUTEP LIMITED financial stats to get the full picture.
No, IMM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IMM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMUTEP LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMMUTEP LIMITED technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMMUTEP LIMITED stock shows the buy signal. See more of IMMUTEP LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.